ALTS insider report lists 1M shares and major warrant holdings
Rhea-AI Filing Summary
ALT5 Sigma Corp (ALTS) disclosed an initial beneficial ownership report. A director by deputization associated with World Liberty Financial, Inc. reported holdings and warrants.
The filer holds 1,000,000 shares of common stock (direct). Derivative positions include warrants for 8,000,000 shares at $7.50, 4,000,000 at $8.25, 4,000,000 at $9.00, and 4,000,000 at $9.75. These warrants are exercisable after issuance, have no expiration date, and are each subject to a 4.99% beneficial ownership limitation.
The filing also lists 99,000,000 pre‑funded warrants exercisable for common stock at an exercise price of $0.001 per share. These are subject to the same 4.99% cap and become exercisable from and after October 16, 2025 following stockholder approval to permit issuance above 19.99% under Nasdaq rules and an amendment increasing authorized common shares. WLFI is deemed a director by deputization through its representatives on the board.
Positive
- None.
Negative
- None.
Insights
Form 3 lists sizable warrant positions with 4.99% cap and contingencies.
This Form 3 establishes baseline ownership: 1,000,000 common shares direct and multiple warrant tranches with exercise prices from $7.50 to $9.75, plus $0.001 pre‑funded warrants. Each instrument carries a 4.99% beneficial ownership limitation and, for the pre‑funded series, contingent exercisability.
The pre‑funded warrants become exercisable from and after October 16, 2025 subject to stockholder approvals tied to the 19.99% Nasdaq threshold and an authorized share increase. Standard warrants have no expiration date, which can extend potential conversion timing but still within the 4.99% cap.
Practical impact depends on approvals and holder decisions; the filing doesn’t specify timing beyond the stated date and conditions. Subsequent filings may provide updates on approvals and any exercises.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Warrants to Purchase Common Stock | -- | -- | -- |
| holding | Warrants to Purchase Common Stock | -- | -- | -- |
| holding | Warrants to Purchase Common Stock | -- | -- | -- |
| holding | Warrants to Purchase Common Stock | -- | -- | -- |
| holding | Pre-Funded Warrants to Purchase Common Stock | -- | -- | -- |
| holding | Common stock, Par Value $0.001 | -- | -- | -- |
Footnotes (1)
- Subject to a 4.99% beneficial ownership limitation, each of the Warrants is exercisable at any time after issuance at the specified exercise price. The Warrants do not have an expiration date. Subject to a 4.99% beneficial ownership limitation, each of the Pre-Funded Warrants is exercisable for one share of Common Stock at an exercise price of $0.001 per Pre-Funded Warrant Share. The Pre-Funded Warrants are exercisable from and after October 16, 2025 following the approval by the Issuer's stockholders at a special meeting to: (i) allow, for the purpose of complying with Nasdaq rules, the issuance of shares underlying the Pre-Funded Warrant in excess of 19.99% of the shares of common stock outstanding immediately prior to their acquisition, and (ii) filed an amendment to its Articles of Incorporation to increase the number of authorized shares of common stock. The Pre-Funded Warrants do not have an expiration date.
